| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.928 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.902 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.899 | |
| pigment accumulation | GO:0043476 | 1 | 0.759 | |
| kidney mesenchyme morphogenesis | GO:0072131 | 4 | 0.722 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.714 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.714 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.708 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.694 | |
| genetic imprinting | GO:0071514 | 27 | 0.670 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.668 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.586 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.555 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.515 | |
| negative regulation of osteoblast differentiation | GO:0045668 | 30 | 0.483 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.482 | |
| negative regulation of peptidyl threonine phosphorylation | GO:0010801 | 6 | 0.482 | |
| nephrogenic mesenchyme morphogenesis | GO:0072134 | 2 | 0.456 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.452 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.433 | |
| regulation of protein localization | GO:0032880 | 231 | 0.428 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.420 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.417 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.411 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.411 | |
| regulation of catenin import into nucleus | GO:0035412 | 5 | 0.397 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.395 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.369 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.366 | |
| cell proliferation involved in heart valve morphogenesis | GO:0003249 | 1 | 0.360 | |
| negative regulation of dna templated transcription elongation | GO:0032785 | 6 | 0.359 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.357 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.356 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.355 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.343 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.332 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.327 | |
| axonogenesis | GO:0007409 | 274 | 0.291 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.285 | |
| mapk cascade | GO:0000165 | 281 | 0.280 | |
| metanephric mesenchyme morphogenesis | GO:0072133 | 4 | 0.276 | |
| positive regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032436 | 23 | 0.275 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.271 | |
| amine metabolic process | GO:0009308 | 45 | 0.267 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.263 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.261 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.260 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.256 | |
| positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:2000060 | 8 | 0.255 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.254 | |
| positive regulation of proteolysis involved in cellular protein catabolic process | GO:1903052 | 31 | 0.251 | |
| dna metabolic process | GO:0006259 | 303 | 0.251 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.248 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.246 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.244 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.234 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.233 | |
| centromeric sister chromatid cohesion | GO:0070601 | 3 | 0.229 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.227 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.225 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.222 | |
| regulation of protein transport | GO:0051223 | 163 | 0.220 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.218 | |
| positive regulation of transforming growth factor beta receptor signaling pathway | GO:0030511 | 12 | 0.212 | |
| axial mesoderm formation | GO:0048320 | 3 | 0.210 | |
| positive regulation of ubiquitin protein transferase activity | GO:0051443 | 4 | 0.209 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.209 | |
| nuclear transport | GO:0051169 | 139 | 0.207 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.204 | |
| wnt signaling pathway involved in somitogenesis | GO:0090244 | 4 | 0.202 | |
| protein ubiquitination | GO:0016567 | 171 | 0.202 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.202 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.202 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.202 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.195 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.195 | |
| protein catabolic process | GO:0030163 | 221 | 0.194 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.193 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.189 | |
| regulation of smad protein import into nucleus | GO:0060390 | 3 | 0.187 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.186 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.185 | |
| cytoplasmic microtubule organization | GO:0031122 | 14 | 0.184 | |
| protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:0042787 | 25 | 0.184 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.182 | |
| gastrulation | GO:0007369 | 116 | 0.180 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.177 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.177 | |
| phagocytosis | GO:0006909 | 66 | 0.176 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.171 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.171 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.169 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.167 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.166 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.164 | |
| protein targeting | GO:0006605 | 143 | 0.163 | |
| regulation of defense response | GO:0031347 | 233 | 0.162 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.161 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.160 | |
| gonad development | GO:0008406 | 141 | 0.159 | |
| endothelial cell activation | GO:0042118 | 1 | 0.159 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.158 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.156 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.156 | |
| single organism nuclear import | GO:1902593 | 95 | 0.154 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.154 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.149 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.147 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.145 | |
| cell cycle switching | GO:0060184 | 1 | 0.142 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.142 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.140 | |
| heart field specification | GO:0003128 | 6 | 0.138 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.131 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.131 | |
| positive regulation of smad protein import into nucleus | GO:0060391 | 2 | 0.130 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.130 | |
| cell adhesion | GO:0007155 | 329 | 0.129 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.129 | |
| intracellular protein transport | GO:0006886 | 204 | 0.128 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.125 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.125 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.125 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.123 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.123 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.123 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 34 | 0.123 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.123 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.122 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.121 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.119 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.119 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.116 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.116 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.114 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.113 | |
| positive regulation of protein import into nucleus | GO:0042307 | 26 | 0.111 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.111 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.110 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.109 | |
| positive regulation of protein localization to nucleus | GO:1900182 | 30 | 0.108 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.108 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.108 | |
| regulation of ligase activity | GO:0051340 | 10 | 0.107 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.107 | |
| secondary heart field specification | GO:0003139 | 6 | 0.104 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.104 | |
| endocytosis | GO:0006897 | 168 | 0.103 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.103 | |
| regulation of cell proliferation involved in heart valve morphogenesis | GO:0003250 | 1 | 0.102 | |
| protein import into nucleus | GO:0006606 | 95 | 0.101 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.100 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.099 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.098 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.097 | |
| jnk cascade | GO:0007254 | 72 | 0.097 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.097 | |
| positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus | GO:1901522 | 7 | 0.097 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.096 | |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 7 | 0.095 | |
| brainstem development | GO:0003360 | 3 | 0.094 | |
| hormone secretion | GO:0046879 | 128 | 0.094 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.094 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.092 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.091 | |
| regulation of peptidyl threonine phosphorylation | GO:0010799 | 12 | 0.091 | |
| germ cell development | GO:0007281 | 185 | 0.091 | |
| regulation of binding | GO:0051098 | 111 | 0.091 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.090 | |
| somite development | GO:0061053 | 81 | 0.090 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.089 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.089 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.089 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.087 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.085 | |
| methylation | GO:0032259 | 134 | 0.084 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.083 | |
| stem cell development | GO:0048864 | 219 | 0.083 | |
| sister chromatid cohesion | GO:0007062 | 12 | 0.083 | |
| dna repair | GO:0006281 | 107 | 0.082 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.082 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.081 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.080 | |
| osteoblast development | GO:0002076 | 17 | 0.080 | |
| positive regulation of protein ubiquitination | GO:0031398 | 27 | 0.080 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.079 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.079 | |
| protein import | GO:0017038 | 101 | 0.078 | |
| negative regulation of transcription elongation from rna polymerase ii promoter | GO:0034244 | 6 | 0.078 | |
| multicellular organism growth | GO:0035264 | 161 | 0.076 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.075 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.075 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.075 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.075 | |
| bone development | GO:0060348 | 120 | 0.074 | |
| t cell activation | GO:0042110 | 289 | 0.074 | |
| protein localization to organelle | GO:0033365 | 185 | 0.074 | |
| epithelial tube formation | GO:0072175 | 130 | 0.074 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.073 | |
| heart formation | GO:0060914 | 16 | 0.072 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.071 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.071 | |
| regulation of jun kinase activity | GO:0043506 | 40 | 0.071 | |
| epithelial to mesenchymal transition involved in endocardial cushion formation | GO:0003198 | 10 | 0.070 | |
| metanephric mesenchyme development | GO:0072075 | 10 | 0.070 | |
| muscle contraction | GO:0006936 | 101 | 0.070 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.067 | |
| mesoderm development | GO:0007498 | 100 | 0.067 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.067 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.066 | |
| positive regulation of jun kinase activity | GO:0043507 | 30 | 0.065 | |
| somitogenesis | GO:0001756 | 69 | 0.065 | |
| locomotory behavior | GO:0007626 | 195 | 0.064 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.064 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.064 | |
| nuclear import | GO:0051170 | 95 | 0.064 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.064 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.064 | |
| dephosphorylation | GO:0016311 | 129 | 0.063 | |
| sensory perception | GO:0007600 | 245 | 0.063 | |
| spermatogenesis | GO:0007283 | 284 | 0.063 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.063 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.062 | |
| heart morphogenesis | GO:0003007 | 178 | 0.061 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.060 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.060 | |
| developmental cell growth | GO:0048588 | 84 | 0.060 | |
| epidermis development | GO:0008544 | 187 | 0.060 | |
| cartilage development | GO:0051216 | 140 | 0.060 | |
| ventricular septum development | GO:0003281 | 42 | 0.060 | |
| regulation of centromeric sister chromatid cohesion | GO:0070602 | 3 | 0.060 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.059 | |
| protein oligomerization | GO:0051259 | 67 | 0.058 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.058 | |
| response to monosaccharide | GO:0034284 | 67 | 0.058 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.058 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.058 | |
| male gamete generation | GO:0048232 | 285 | 0.057 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.057 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.057 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.057 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.056 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.056 | |
| cytokine production | GO:0001816 | 319 | 0.056 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.056 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.055 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.055 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.055 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.055 | |
| regulation of protein stability | GO:0031647 | 52 | 0.055 | |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 13 | 0.055 | |
| striated muscle contraction | GO:0006941 | 45 | 0.054 | |
| neural tube formation | GO:0001841 | 108 | 0.054 | |
| regulation of ossification | GO:0030278 | 112 | 0.054 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.054 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.054 | |
| chemotaxis | GO:0006935 | 247 | 0.054 | |
| positive regulation of activin receptor signaling pathway | GO:0032927 | 3 | 0.053 | |
| chondrocyte development | GO:0002063 | 24 | 0.053 | |
| connective tissue development | GO:0061448 | 179 | 0.053 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.052 | |
| mesenchyme development | GO:0060485 | 152 | 0.052 | |
| positive regulation of intracellular protein transport | GO:0090316 | 42 | 0.052 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.052 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.052 | |
| regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:2000058 | 14 | 0.052 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.051 | |
| specification of organ identity | GO:0010092 | 30 | 0.050 | |
| response to bmp | GO:0071772 | 14 | 0.050 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.050 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.050 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.050 | |
| embryonic skeletal joint development | GO:0072498 | 13 | 0.050 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.050 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.049 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.049 | |
| gtp metabolic process | GO:0046039 | 144 | 0.049 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.048 | |
| axon guidance | GO:0007411 | 141 | 0.048 | |
| response to growth factor | GO:0070848 | 198 | 0.048 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.048 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.047 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.047 | |
| hindbrain development | GO:0030902 | 128 | 0.047 | |
| dna alkylation | GO:0006305 | 43 | 0.047 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.047 | |
| embryonic skeletal joint morphogenesis | GO:0060272 | 11 | 0.046 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.046 | |
| inflammatory response | GO:0006954 | 244 | 0.046 | |
| ossification | GO:0001503 | 216 | 0.045 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.045 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.045 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.045 | |
| positive regulation of chondrocyte differentiation | GO:0032332 | 13 | 0.044 | |
| metanephros development | GO:0001656 | 79 | 0.044 | |
| optic placode formation | GO:0001743 | 2 | 0.044 | |
| activation of mapkkk activity | GO:0000185 | 1 | 0.044 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.044 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.044 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.044 | |
| artery development | GO:0060840 | 53 | 0.044 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.043 | |
| organ growth | GO:0035265 | 117 | 0.043 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.043 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.043 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.042 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.042 | |
| amide transport | GO:0042886 | 138 | 0.042 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.042 | |
| synaptic transmission | GO:0007268 | 329 | 0.042 | |
| adult behavior | GO:0030534 | 135 | 0.042 | |
| protein homooligomerization | GO:0051260 | 43 | 0.042 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.042 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.041 | |
| respiratory system development | GO:0060541 | 190 | 0.041 | |
| cellular homeostasis | GO:0019725 | 240 | 0.041 | |
| peptide transport | GO:0015833 | 133 | 0.041 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.041 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.041 | |
| adult walking behavior | GO:0007628 | 41 | 0.041 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.040 | |
| forebrain development | GO:0030900 | 302 | 0.040 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.040 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.039 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.039 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.039 | |
| regulation of secretion | GO:0051046 | 274 | 0.039 | |
| cardiac chamber development | GO:0003205 | 108 | 0.039 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.039 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.039 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.039 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.039 | |
| positive regulation of growth | GO:0045927 | 104 | 0.038 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.038 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.038 | |
| regulation of establishment of planar polarity | GO:0090175 | 28 | 0.038 | |
| histone methylation | GO:0016571 | 71 | 0.038 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.037 | |
| muscle tissue development | GO:0060537 | 308 | 0.037 | |
| regulation of activin receptor signaling pathway | GO:0032925 | 10 | 0.037 | |
| palate development | GO:0060021 | 76 | 0.037 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.037 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.037 | |
| biomineral tissue development | GO:0031214 | 64 | 0.037 | |
| positive regulation of protein export from nucleus | GO:0046827 | 4 | 0.037 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.037 | |
| sterol transport | GO:0015918 | 38 | 0.036 | |
| osteoblast proliferation | GO:0033687 | 18 | 0.036 | |
| heart contraction | GO:0060047 | 93 | 0.036 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.036 | |
| membrane organization | GO:0061024 | 245 | 0.036 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.036 | |
| blood circulation | GO:0008015 | 195 | 0.035 | |
| respiratory tube development | GO:0030323 | 167 | 0.035 | |
| dendrite development | GO:0016358 | 115 | 0.035 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.035 | |
| response to radiation | GO:0009314 | 165 | 0.035 | |
| odontogenesis | GO:0042476 | 78 | 0.035 | |
| commitment of multipotent stem cells to neuronal lineage in forebrain | GO:0021898 | 3 | 0.035 | |
| cell cycle switching mitotic to meiotic cell cycle | GO:0051728 | 1 | 0.035 | |
| gastrulation with mouth forming second | GO:0001702 | 29 | 0.035 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.035 | |
| female gamete generation | GO:0007292 | 74 | 0.035 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.035 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.034 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.034 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.034 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.034 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.034 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.034 | |
| digestive system development | GO:0055123 | 200 | 0.034 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.033 | |
| wound healing | GO:0042060 | 157 | 0.033 | |
| mesonephros development | GO:0001823 | 97 | 0.033 | |
| segmentation | GO:0035282 | 93 | 0.033 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.033 | |
| glucose metabolic process | GO:0006006 | 92 | 0.033 | |
| cardiac septum development | GO:0003279 | 59 | 0.033 | |
| midbrain development | GO:0030901 | 35 | 0.032 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.032 | |
| insulin secretion | GO:0030073 | 89 | 0.032 | |
| chromatin organization | GO:0006325 | 206 | 0.032 | |
| regulation of cell fate commitment | GO:0010453 | 19 | 0.032 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.032 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.032 | |
| synapse organization | GO:0050808 | 125 | 0.032 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.032 | |
| transmembrane transport | GO:0055085 | 412 | 0.032 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.032 | |
| nodal signaling pathway involved in determination of left right asymmetry | GO:0038107 | 2 | 0.031 | |
| cell recognition | GO:0008037 | 83 | 0.031 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.031 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.031 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.031 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.031 | |
| bone morphogenesis | GO:0060349 | 78 | 0.031 | |
| neuron projection guidance | GO:0097485 | 141 | 0.031 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.031 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.031 | |
| body morphogenesis | GO:0010171 | 45 | 0.031 | |
| regulation of cell proliferation involved in heart morphogenesis | GO:2000136 | 15 | 0.031 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.030 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.030 | |
| canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation | GO:0060823 | 1 | 0.030 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.030 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.030 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.030 | |
| stem cell differentiation | GO:0048863 | 268 | 0.030 | |
| endothelium development | GO:0003158 | 45 | 0.030 | |
| rhythmic process | GO:0048511 | 174 | 0.030 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.030 | |
| skeletal system development | GO:0001501 | 356 | 0.030 | |
| regulation of cell migration | GO:0030334 | 219 | 0.030 | |
| lung development | GO:0030324 | 164 | 0.030 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.030 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.029 | |
| fat cell differentiation | GO:0045444 | 160 | 0.029 | |
| negative regulation of execution phase of apoptosis | GO:1900118 | 4 | 0.029 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.029 | |
| organelle localization | GO:0051640 | 179 | 0.029 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.029 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.028 | |
| regulation of sister chromatid cohesion | GO:0007063 | 5 | 0.028 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.028 | |
| regionalization | GO:0003002 | 337 | 0.028 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.028 | |
| golgi to endosome transport | GO:0006895 | 3 | 0.028 | |
| negative regulation of intracellular protein transport | GO:0090317 | 27 | 0.028 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.028 | |
| rna processing | GO:0006396 | 105 | 0.028 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.028 | |
| hair follicle development | GO:0001942 | 85 | 0.028 | |
| osteoblast fate commitment | GO:0002051 | 4 | 0.028 | |
| endocardium development | GO:0003157 | 10 | 0.027 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.027 | |
| compound eye development | GO:0048749 | 1 | 0.027 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.027 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.027 | |
| regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry | GO:1900094 | 2 | 0.027 | |
| mitochondrion organization | GO:0007005 | 134 | 0.027 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.027 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.026 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.026 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.026 | |
| skin development | GO:0043588 | 220 | 0.026 | |
| mesoderm formation | GO:0001707 | 62 | 0.026 | |
| regulation of nodal signaling pathway | GO:1900107 | 4 | 0.026 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.026 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.026 | |
| dna methylation | GO:0006306 | 43 | 0.026 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.026 | |
| rna 3 end processing | GO:0031123 | 20 | 0.026 | |
| gland development | GO:0048732 | 330 | 0.026 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.026 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.026 | |
| liver development | GO:0001889 | 66 | 0.026 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.026 | |
| sebaceous gland development | GO:0048733 | 7 | 0.025 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.025 | |
| smad protein complex assembly | GO:0007183 | 1 | 0.025 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.025 | |
| cell fate commitment | GO:0045165 | 210 | 0.025 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.025 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.025 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.025 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.025 | |
| nodal signaling pathway | GO:0038092 | 10 | 0.025 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.025 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.025 | |
| establishment of planar polarity of embryonic epithelium | GO:0042249 | 16 | 0.025 | |
| regulation of osteoblast proliferation | GO:0033688 | 15 | 0.025 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.025 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.025 | |
| histone lysine methylation | GO:0034968 | 50 | 0.024 | |
| negative regulation of catenin import into nucleus | GO:0035414 | 2 | 0.024 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.024 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.024 | |
| nephron tubule development | GO:0072080 | 84 | 0.024 | |
| hemoglobin metabolic process | GO:0020027 | 13 | 0.024 | |
| activation of immune response | GO:0002253 | 138 | 0.024 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.024 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.024 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.024 | |
| regulation of rna stability | GO:0043487 | 26 | 0.024 | |
| microtubule based process | GO:0007017 | 236 | 0.024 | |
